Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital

MEK/ERK/1/2 sensitive vascular changes coincide with retinal functional deficit, following transient ophthalmic artery occlusion

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Determination of peripapillary vessel density in optic disc drusen using EDI-OCT and OCT angiography

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. High-throughput sequencing reveals no viral pathogens in eight cases of ocular adnexal extranodal marginal zone B-cell lymphoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Bruch's membrane allows unhindered passage of up to 2 μm latex beads in an in vivo porcine model

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Distribution of CGRP and its receptor components CLR and RAMP1 in the rat retina

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Non-invasive tryptophan fluorescence measurements as a novel method of grading cataract

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Identifying New Antimigraine Targets: Lessons from Molecular Biology

    Research output: Contribution to journalReviewpeer-review

  2. Oral rimegepant for migraine prevention

    Research output: Contribution to journalComment/debateResearchpeer-review

View graph of relations

Retinal ischemia remains a major cause of blindness in the world with few acute treatments available. Recent emphasis on retinal vasculature and the ophthalmic artery's vascular properties after ischemia has shown an increase in vasoconstrictive functionality, as previously observed in cerebral arteries following stroke. Specifically, endothelin-1 (ET-1) receptor-mediated vasoconstriction regulated by the MEK/ERK1/2 pathway. In this study, the ophthalmic artery of rats was occluded for 2 h with the middle cerebral artery occlusion model. MEK/ERK1/2 inhibitor U0126 was administered at 0, 6, and 24 h following reperfusion and the functional properties of the ophthalmic artery were evaluated at 48 h post reperfusion. Additionally, retinal function was evaluated at day 1, 4, and 7 after reperfusion. Occlusion of the ophthalmic artery led to a significant increase of endothelin-1 mediated vasoconstriction which can be attenuated by U0126 treatment, most evident at higher ET-1 concentrations of 10-7 M (Emax151.0 ± 22.0% of 60 mM K+), vs non-treated ischemic arteries Emax 212.1 ± 14.7% of 60 mM K+). Retinal function also deteriorated following ischemia and was improved with treatment with a-wave amplitudes of 725 ± 36 μV in control, 560 ± 21 μV in non-treated, and 668 ± 73 μV in U0126 treated at 2 log cd*s/m2 luminance in the acute stages (1 days post-ischemia). Full spontaneous retinal recovery was observed at day 7 regardless of treatment. In conclusion, this is the first study to show a beneficial in vivo effect of U0126 on vascular contractility following ischemia in the ophthalmic artery. Coupled with the knowledge obtained from cerebral vasculature, these results point towards a novel therapeutic approach following ischemia-related injuries to the eye.

Original languageEnglish
JournalExperimental Eye Research
Pages (from-to)142-149
Number of pages8
Publication statusPublished - 2019

    Research areas

  • Endothelin-1, Ophthalmic artery, Retinal ischemia, Vascular changes, mek/erk1/2, Electroretinography, Immunohistochemistry, Myography, Muscle, Smooth, Vascular/physiology, Rats, Wistar, Nitriles/pharmacology, Rats, Male, Vasoconstriction/physiology, Enzyme Inhibitors/pharmacology, Ischemia/physiopathology, Animals, Mitogen-Activated Protein Kinases/antagonists & inhibitors, MAP Kinase Signaling System/physiology, Butadienes/pharmacology, Ophthalmic Artery/physiopathology, Retina/physiopathology, Infarction, Middle Cerebral Artery/physiopathology, Microscopy, Fluorescence

ID: 55802422